Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Total Debt: 2024-2025

Historic Total Debt for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $9.7 million.

  • Kura Oncology's Total Debt rose 2.12% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 2.12%. This contributed to the annual value of $9.5 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Kura Oncology's Total Debt stood at $9.7 million, which was up 0.54% from $9.6 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Total Debt peaked at $9.7 million during Q3 2025, and registered a low of $9.4 million during Q1 2024.
  • Moreover, its 2-year median value for Total Debt was $9.5 million (2024), whereas its average is $9.5 million.
  • Data for Kura Oncology's Total Debt shows a peak YoY increased of 2.12% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Kura Oncology's Total Debt stood at $9.5 million in 2024, then increased by 2.12% to $9.7 million in 2025.
  • Its Total Debt stands at $9.7 million for Q3 2025, versus $9.6 million for Q2 2025 and $9.6 million for Q1 2025.